{"id":"NCT00294047","sponsor":"GlaxoSmithKline","briefTitle":"Study to Evaluate the Efficacy of the Human Papillomavirus Vaccine in Healthy Adult Women of 26 Years of Age and Older","officialTitle":"A Study to Evaluate Safety, Immunogenicity and Efficacy of GSK Biologicals HPV-16/18 L1/AS04 Vaccine Administered Intramuscularly According to a Three-dose Schedule (0, 1, 6 Month) in Healthy Adult Female Subjects Aged 26 Years and Above","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-02-16","primaryCompletion":"2014-01-29","completion":"2014-01-29","firstPosted":"2006-02-20","resultsPosted":"2012-03-27","lastUpdate":"2020-01-02"},"enrollment":5752,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"PREVENTION"},"conditions":["Infections, Papillomavirus","Papillomavirus Vaccines"],"interventions":[{"type":"BIOLOGICAL","name":"Cervarix","otherNames":[]},{"type":"BIOLOGICAL","name":"Placebo control","otherNames":[]}],"arms":[{"label":"Cervarix Group","type":"EXPERIMENTAL"},{"label":"Aluminium Hydroxide Group","type":"PLACEBO_COMPARATOR"}],"summary":"This is a multicentre study in which women were planned to receive either the Human Papillomavirus Vaccine (HPV) vaccine or control. Under Protocol Amendment 3, study participation will last approximately 48 months and involves a total of eleven scheduled visits. Under Protocol Amendment 4, study participation will last up to 84 months and involves a maximum of seventeen scheduled visits.","primaryOutcome":{"measure":"Number of Subjects With Persistent Infection (6-month Definition) With Human Papillomavirus (HPV)-16 or HPV-18 and/or With Histopathologically-confirmed Cervical Intraepithelial Neoplasia (CIN)1+ Associated With HPV-16 and/or -18 Cervical Infection.","timeFrame":"Up to Month 48","effectByArm":[{"arm":"Cervarix Group","deltaMin":7,"sd":null},{"arm":"Aluminium Hydroxide Group","deltaMin":36,"sd":null}],"pValues":[]},"eligibility":{"minAge":"26 Years","sex":"FEMALE","healthyVolunteers":true,"inclusionCount":7,"exclusionCount":16},"locations":{"siteCount":75,"countries":["United States","Australia","Canada","Mexico","Netherlands","Peru","Philippines","Portugal","Russia","Singapore","Thailand","United Kingdom"]},"refs":{"pmids":["19221517","25189358","18845199","27373900","27998562","31824976","31273942","26685704"],"seeAlso":["https://www.clinicalstudydatarequest.com"]},"adverseEventsSummary":{"seriousAny":{"events":291,"n":2881},"commonTop":["Pain","Headache","Fatigue","Redness","Swelling"]}}